News & Events

Faus Moliner recognized once again in the 2025 edition of The Legal 500 (Legalease)

Faus Moliner appears in Tier 1 in the area of Healthcare and Life Sciences

3 Apr 2025

This year Jordi Faus is in the Hall of Fame and Xavier Moliner continues to appear as leading individual, while Lluís Alcover has been identified...

Chambers & Partners has published the 2025 edition of the Chambers Europe Guide and Faus Moliner has once again obtained the highest possible recognition

Faus Moliner

25 Mar 2025

The Chambers Europe Guide is a prestigious publication. The rankings are the result of extensive research carried out by its in-house research team, which conducts...

Jordi Faus, Xavier Moliner y Eduard Rodellar recognized in the guide The Best Lawyers in Spain

Faus Moliner

5 Dec 2024

The legal guide The Best Lawyers in Spain has recently launched its edition for the year 2025, in which, on the basis of nominations by...

Jordi Faus and Lluís Alcover have participated in a session on the regulations applicable to the financing of therapies in Spain

Faus Moliner

29 Nov 2024

On 7 and 8 November, the XXX National Health Law Congress was held, one of the most important events of the year in Spain in...

Lluís Alcover took part in the session on Access to Orphan Drugs: Present and Future

Faus Moliner

22 Nov 2024

The 17th International Congress on Rare Diseases: “Early Diagnosis and Advances in Research: Opening Doors to Hope”, was held in Murcia on November 22 and...

The event, organized by the Weber Foundation and co-sponsored by Aelmhu, took place on 26 September 2024

Faus Moliner

2 Oct 2024

Lluís Alcover has participated in the round table discussion on “How does the Royal Decree on Health Technology Assessment affect orphan drugs?”, together with Max...

The Congress was held on September 19 and 20, 2024

Faus Moliner

2 Oct 2024

Joan Carles Bailach has participated in the panel discussion on Transparency and confidentiality in drug pricing, together with RobertoGarcía, President and CEO of Meiji Pharma...

Jordi Faus and Lluís Alcover participated in the meeting held in Madrid on September 17

Faus Moliner

26 Sep 2024

Jordi Faus and Lluís Alcover participated in this interesting meeting on transferable exclusivity vouchers and hospital exemptions organized by Diariofarma with the purpose of discussing...

Faus Moliner recognized once again in the 2025 edition of The Legal 500 (Legalease)

Faus Moliner appears in Tier 1 in the area of Healthcare and Life Sciences

Faus Moliner, ranked in Band 1 for Life Sciences in the Chambers Europe 2025 Guide

Chambers & Partners has published the 2025 edition of the Chambers Europe Guide and Faus Moliner has once again obtained the highest possible recognition

Three lawyers of Faus & Moliner appear in the Best Lawyers Guide 2025 in Spain

Jordi Faus, Xavier Moliner y Eduard Rodellar recognized in the guide The Best Lawyers in Spain

Faus Moliner participates in the XXX National Health Law Congress

Jordi Faus and Lluís Alcover have participated in a session on the regulations applicable to the financing of therapies in Spain

XVII CONGRESO INTERNACIONAL DE ENFERMEDADES RARAS

Lluís Alcover took part in the session on Access to Orphan Drugs: Present and Future

Faus Moliner participates in the Fifth Edition of the Summer Course NewsRARE

The event, organized by the Weber Foundation and co-sponsored by Aelmhu, took place on 26 September 2024

Faus Moliner participates in the Third Congress of Pharmaceutical Law organized by the Section of Pharmaceutical Law of ICAM

The Congress was held on September 19 and 20, 2024

Faus Moliner participates in the Colloquium “Two great novelties: hospital exemptions and transferable exclusivity vouchers” organized by Diariofarma

Jordi Faus and Lluís Alcover participated in the meeting held in Madrid on September 17

Awards

Uso de cookies